Inhibitors of protein synthesis

Cancer Investigation

Volumn 17, Issue 1, 1999, Pages 87-92

  Leviton, Ira ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHLORAMPHENICOL; CLINDAMYCIN; MACROLIDE; TETRACYCLINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; BACTERIAL INFECTION; DRUG ABSORPTION; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 0032965699     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1080/07357909909011720     Document Type: Review

References (30)

1. Spots CR, Stainier RY: Mechanism of streptomycin action on bacteria: A unitary hypothesis. Nature 192:633-637, 1961.
2. Dickie P, Bryan LE, Pickard MA: Effect of enzymatic adenylation on dihydrostreptomycin accumulation in Escherichia coli carrying an R-factor: Model explaining aminoglycoside resistance by inactivating mechanisms. Antimicrob Agents Chemotber 14:569-580, 1978.
3. Moellering RC Jr, Wennersten C, Weinberg AN: Studies on antibiotic synergism against enterococci: I. Bacteriologic studies. J Lab Clin Med 77:821-828, 1971.
4. Odio W, Van Leier E, Klastersky J: Concentrations of gentamicin in bronchial secretions after intramuscular and indotracheal administration. J Clin Pharmacol 15:518-524, 1975.
5. Lipsky JJ, Cheng L, Sacktor B, Lietman PS: Gentamicin uptake by renal tubule brush border membrane vesicles. J Pharmacol Exp Tber 215:390-393, 1980.
6. Tran Ba Huy P, Muelemans A, Wassef M, Manuel C, Sterkers O, Amiel C: Gentamicin persistence in rat endolymph and perilymph after a two-day constant infusion. Antimicrob Agents Chemother 22:344-346, 1983.
7. Wright JM, Collier B: The Effects of neomycin upon transmitter release and action. J Pharmacol Exp Ther 200:576-587, 1977.
8. 14C-erythromycin to Escherichia coli ribosomes. Antimicrob Agents Chemother 6:474-478, 1974.
9. Haight TH, Finland M: The antibacterial action of erythromycin. Proc Soc Exp Biol 81:175-183, 1952.
10. Lai CJ, Weisblum B: Altered methylalion of ribosomal RNA in an erythromycin-resistant strain of Staphylococcus aureus. Proc Natl Acad Sci USA 68:856-860, 1971.
11. Philipson A, Sabath LD, Charles D: Transplacental passage of erythromycin and clindamycin. N Engl J Med 288:1219-1221, 1973.
12. Mao JCH, Tardrew PL: Demethylation of erythromycin by rabbit tissue in vitro. Biochem Pharmacol 14:1049-1058, 1965.
13. Itoh Z, Suzuki T, Nakaya M, Inoue M, Mitsubashi S: Gastrointestinal motor-stimulating activity of macrolide antibiotics and analysis of their side effects on the canine gut. Antimicrob Agents Chemother 26:863-869, 1984.
14. Braun P: Hepatotoxicity of erythromycin. J Infect Dis 119:300-306, 1969.
15. Karmody CS, Weinstein L: Reversible sensorineural hearing loss with intravenous erythromycin lactobionate. Ann Otol Rbinol Laryngol, 86:9-11, 1977.
16. Periti P, Mazzei T, Mini E, Novelli A: Pharmacokinetic drug interactions of macrolides. Clin Pharmaocokin 23:106-131, 1993.
17. Reusser F: Effect of lincomycin and clindamycin on peptide chain initiation. Antimicrob Agents Chemother 7:32-37, 1975.
18. Panzer JD, Brown DC, Epstein WL, Lipson RC, Mahaffey HW, Atkinson WH: Clindamycin levels in various body tissues and fluids. J Clin Pharmacol 12:259-262, 1972.
19. Wagner, JG, Novak E, Patel NC, Chidester CG, Lummis WL: Absorption, excretion, and half-life of clinimycin in normal adult males. Am J Med Sci 256:25-37, 1968.
20. Neu HC, Prince A, Neu CO, Garvey GJ: Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis 135 (Suppl):S120-125, 1977.
21. Beard NS, Armentrout SA, Weisberger AS: Inhibition of mammalian protein synthesis by antibiotics. Pharmacol Rev 21:213-245, 1969.
22. Grossman ER, Walcheck A, Freedman H: Tetracycline and permanent teeth: The relationship between dose and tooth color. Pediatrics 47:567-570, 1971.
23. Schultz JC, Adamson JS Jr, Workman WW, Norman TD: Fatal liver disease after intravenous administration of tetracycline in high doses. N Engl J Med 269:999-1004, 1963.
24. Pestka S: Inhibitors of ribosome functions. Annu Rev Microbiol 25:487-562, 1971.
25. Benveniste R, Davies J: Mechanisms of antibiotic resistance in bacteria. Annu Rev Biochem 42:471-506, 1973.
26. Glazko AJ, Dill AW, Kinkel JR, Goulet JR, Holloway WJ, Buchanan RA: Absorption and excretion of parenteral doses of chloramphenicol sodium succinate in comparison with peroral doses of chloramphenicol. Clin Pharmacol Ther 21:104, 1977.
27. Glazko AJ, Wolf LM, Dill WA, Bratton AC: Biochemical studies on chloramphenicol (chloromycetin). J Pharmacol Exp Ther 96: 445-459, 1949.
28. Yunis AA, Bloomberg GR: Chloramphenicol toxicity: Clinical features and pathogenesis. Prog Hematol 4:138-159, 1964.
29. Yunis AA: Chloramphenicol-induced bone marrow suppression. Semin Hematol 10:225-234, 1973.
30. Weiss CF, Glazko AJ, Weston JK: Chloramphenicol in the newborn infant: A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med 262:787-794, 1960.